Removing cancer without a stitch
Cancer Center expert featured in Memphis, Tennessee news report
The University of Cincinnati Cancer Center's Moamen Gabr, MD, was featured in a news report from Memphis, Tennessee television station Action News 5 discussing endoscopic submucosal dissection, a new approach to remove certain gastrointestinal tumors without surgery.
In the procedure, a thin, flexible scope with tiny tools and a camera is inserted through the mouth or rectum. When it reaches the tumor, a special fluid is released to lift the cancerous lesion away from healthy tissue. Then, doctors can safely peel away the tumor from the deeper lining of the digestive tract.
“We’re cutting through all the lateral margins until that whole precancerous area is removed,” explained Gabr, a Cancer Center physician and associate professor in UC's College of Medicine. “The key advantage is that we’re keeping that organ in place, no incisions from the outside, and no one likes to have an incision, even small ones."
Gabr stressed the key to make this method more widespread and useful is early detection of GI cancers.
Featured photo at top of a medical professional holding a colonoscope. Photo/robertprzybysz/iStock.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.